X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Castrate Resistant Prostate Cancer Therapeutics Companies

This report lists the top Castrate Resistant Prostate Cancer Therapeutics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Castrate Resistant Prostate Cancer Therapeutics industry.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Chronic Disorder Drugs Research Oncology Drugs Research Metastatic Castration-Resistant Prostate Cancer (mCRPC) Industry Companies

Castrate Resistant Prostate Cancer Therapeutics Top Companies

  1. Sanofi

  2. Johnson & Johnson

  3. Bayer AG

  4. Dendreon Pharmaceuticals LLC

  5. Pfizer Inc

*Disclaimer: Top companies sorted in no particular order

Castrate Resistant Prostate Cancer Therapeutics Market Major Players

Castrate Resistant Prostate Cancer Therapeutics Market Concentration

Castrate Resistant Prostate Cancer Therapeutics Market Concentration

Castrate Resistant Prostate Cancer Therapeutics Company List

                          • Sanofi

                          • Pfizer Inc

                          • Johnson & Johnson

                          • Bayer AG

                          • Dendreon Pharmaceuticals LLC

                          • AstraZeneca Plc

                          • Kintor Pharmaceutical Limited

                          • Clovis Oncology

                          • Glaxosmithkline Plc

                          • Aragon Pharmaceuticals, Inc


                      Specific to Castrate Resistant Prostate Cancer Therapeutics Market
                      Need More Details On Market Players And Competitors?
                      Download Sample

                      Castrate-Resistant Prostate Cancer Market Report Snapshots

                      Castrate-Resistant Prostate Cancer Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)